4.7 Article

NRF2-regulation in brain health and disease: Implication of cerebral inflammation

期刊

NEUROPHARMACOLOGY
卷 79, 期 -, 页码 298-306

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2013.11.004

关键词

Neuroinflammation; NRF2; Anti-oxidants

资金

  1. Swedish Research Council [VR2009-2630, 2012-2992, ALFGBG-142881]
  2. European Union [HEALTHF2-2009-241778]
  3. Leducq foundation [DSRR_234404]
  4. Ahlen-stiftelsen
  5. Wilhelm and Martina Lundgren Foundation
  6. Swedish Brain Foundation [FO2013-095]
  7. National Institutes of Health [R01 GM044842]
  8. Foundation Olle Engkvist Byggmastare

向作者/读者索取更多资源

The nuclear factor erythroid 2 related factor 2 (NRF2) is a key regulator of endogenous inducible defense systems in the body. Under physiological conditions NRF2 is mainly located in the cytoplasm. However, in response to oxidative stress, NRF2 translocates to the nucleus and binds to specific DNA sites termed anti-oxidant response elements or electrophile response elements to initiate transcription of cytoprotective genes. Acute oxidative stress to the brain, such as stroke and traumatic brain injury is increased in animals that are deficient in NRF2. Insufficient NRF2 activation in humans has been linked to chronic diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis. New findings have also linked activation of the NRF2 system to anti-inflammatory effects via interactions with NF-kappa B. Here we review literature on cellular mechanisms of NRF2 regulation, how to maintain and restore NRF2 function and the relationship between NRF2 regulation and brain damage. We bring forward the hypothesis that inflammation via prolonged activation of key kinases (p38 and GSK-3 beta) and activation of histone deacetylases gives rise to dysregulation of the NRF2 system in the brain, which contributes to oxidative stress and injury. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据